These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 410692)
21. [Single intravenous glibenclamide-glucose loading as a prediction test (author's transl)]. Pfeiffer EF; Raptis S; Schröder KE Dtsch Med Wochenschr; 1974 Jun; 99(24):1281-94. PubMed ID: 4210532 [No Abstract] [Full Text] [Related]
22. Influence of verapamil on human glucose tolerance. Röjdmark S; Andersson DE Am J Cardiol; 1986 Feb; 57(7):39D-43D. PubMed ID: 3082174 [TBL] [Abstract][Full Text] [Related]
25. Topical application of the hypoglycemic agent glibenclamide and changes in blood glucose, plasma insulin (IRI) levels and plasma concentration of glibenclamide in normal rats. Yamamoto T; Katakabe K; Akiyoshi K; Kan K; Asano T; Okumura M Diabetes Res Clin Pract; 1990 Jan; 8(1):19-22. PubMed ID: 2105197 [TBL] [Abstract][Full Text] [Related]
26. Glucose, FFA, IRI and GH response to I.V. glibenclamide. Rastogi GK; Dash RJ; Sinha MK Horm Metab Res; 1973 Jul; 5(4):303. PubMed ID: 4199903 [No Abstract] [Full Text] [Related]
27. Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus. Shapiro ET; Van Cauter E; Tillil H; Given BD; Hirsch L; Beebe C; Rubenstein AH; Polonsky KS J Clin Endocrinol Metab; 1989 Sep; 69(3):571-6. PubMed ID: 2503533 [TBL] [Abstract][Full Text] [Related]
28. [Mechanism of action of combined administration of glibenclamide and insulin in type II diabetics with secondary failure of oral treatment]. Schmidt FH; Klujko J; Kühnle HF; Reiter J Klin Wochenschr; 1986 Oct; 64(20):1021-3. PubMed ID: 3097384 [TBL] [Abstract][Full Text] [Related]
29. Compared to glibenclamide, repaglinide treatment results in a more rapid fall in glucose level and beta-cell secretion after glucose stimulation. Abbink EJ; van der Wal PS; Sweep CG; Smits P; Tack CJ Diabetes Metab Res Rev; 2004; 20(6):466-71. PubMed ID: 15386823 [TBL] [Abstract][Full Text] [Related]
30. Steady state plasma insulin response to continuous glucose infusion in normal and diabetic subjects. Reaven GM; Farquhar JW Diabetes; 1969 May; 18(5):273-9. PubMed ID: 5795851 [No Abstract] [Full Text] [Related]
31. Insulin response in patients receiving concentrated infusions of glucose and casein hydrolysate for complete parenteral nutrition. Sanderson I; Deitel M Ann Surg; 1974 Apr; 179(4):387-94. PubMed ID: 4205794 [No Abstract] [Full Text] [Related]
32. Intravenous glucose tolerance and early insulin response. Studies on a random sample of women aged 50 and patients with diabetes mellitus. Blohmé G Acta Med Scand Suppl; 1974; 566():1-121. PubMed ID: 4533586 [No Abstract] [Full Text] [Related]
33. [Increase of the betazytotropic effect of intravenous arginine administration through glibenclamide in subjects with healthy metabolism and in patients with latent and manifest diabetes]. Sorge F; Neuhaus GA Med Welt; 1975 Oct; 26(42):1922-7. PubMed ID: 810637 [No Abstract] [Full Text] [Related]